lymphocyte malignancies
Showing 1 - 25 of 4,062
Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)
Suspended
- Hematologic Neoplasms
- donor lymphocyte infusion
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 30, 2022
Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))
Recruiting
- Solid Tumor Malignancies
- Autologous lymphocyte infusion (ALI)
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)
Recruiting
- Myeloid Diseases
- Antithymocyte globulin (Rabbit)
- +5 more
-
Middletown, New Jersey
- +1 more
Jan 19, 2023
Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte
Recruiting
- Lymphoid Leukemia, Acute
- +2 more
- T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc
May 24, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Radiation
- +3 more
-
New Hyde Park, New YorkCohen Children's Medical Center
Apr 6, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Total-Body Irradiation
- +5 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)
Active, not recruiting
- B-Cell Non-Hodgkin Lymphoma
- +5 more
- Ipilimumab
- Lenalidomide
-
Houston, TexasM D Anderson Cancer Center
Aug 6, 2021
Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,
Completed
- Acute Myeloid Leukemia
- +10 more
- total marrow irradiation
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021
Leukemia, Lymphoma Trial in Houston (HSCT, DLI)
Completed
- Leukemia
- Lymphoma
- HSCT
- DLI
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 9, 2021
Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Advanced Malignant Solid Tumor, Metastatic Carcinoma in the Liver, Metastatic Carcinoma in the Lung Trial in Houston (drug,
Recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Anti-GITR Agonistic Monoclonal Antibody BMS-986156
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Lund (Clofarabine for remission induction, Etoposide for remission
Completed
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Clofarabine for remission induction
- +7 more
-
Lund, SwedenLund University Hospital
Feb 17, 2021
Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)
Recruiting
- Anaplastic Ependymoma
- +14 more
- Etoposide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Myeloproliferative Tumor, Recurrent Acute Lymphoblastic Leukemia Trial
Completed
- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- +10 more
- Ipilimumab
- +2 more
-
Duarte, California
- +12 more
Jun 23, 2021
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (donor lymphocytes)
Completed
- Leukemia
- +3 more
- donor lymphocytes
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 21, 2020
Leukemia, Lymphoma Trial in Chongqing (Anti-CD30-CAR-transduced T cells)
Unknown status
- Leukemia
- Lymphoma
- Anti-CD30-CAR-transduced T cells
-
Chongqing, Chongqing, ChinaSouthwest Hospital of Third Millitary Medical University
Jun 23, 2019
Adult T-Cell Lymphoma/Leukaemia, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in Wuhan (Anti-CD30
Recruiting
- Adult T-Cell Lymphoma/Leukaemia
- +5 more
- Anti-CD30 CAR T cells
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019
Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor, Unclassifiable
Withdrawn
- Acute Bilineal Leukemia
- +11 more
- Rivogenlecleucel
- Rimiducid
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 12, 2020
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Liver Cancer, Pancreatic Cancer, Brain Tumor Trial in Beijing (anti-CD133-CAR vector-transduced T cells)
Completed
- Liver Cancer
- +6 more
- anti-CD133-CAR vector-transduced T cells
-
Beijing, Beijing, ChinaBiotherapeutic Department and Pediatrics Department of Chinese P
Dec 15, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022